Ep188: Art Krieg on Innate Immune System Activators for Cancer
The Long Run with Luke Timmerman
00:00
Clinical signal with TLR9 agonist
Art reviews Checkmate clinical responses in melanoma, combo benefits with checkpoint inhibitors, and limitations.
Play episode from 36:17
Transcript
